Roche Completes Acquisition of San Francisco’s Genentech
On Thursday, Swiss drugmaker Roche announced that it has completed its acquisition of San Francisco biotechnology firm Genentech. Roche owned about 56% of Genentech prior to launching a takeover bid last year. Roche said it now owns 93% of Genentech's shares, following the completion of its $93-a-share tender offer.
- "Roche Completes Purchase of Genentech" (Tansey, San Francisco Chronicle, 3/27).
- "Roche Completes Genentech Takeover" (Johnson, San Jose Mercury News, 3/26).